[PDF][PDF] Leucemia mieloide crónica. Interferón vs transplante de médula ósea
J de Diego Flores-Chapa - anmm.org.mx
S-32 Gac Méd Méx Vol. 136 Suplemento No. 2, 2000 antileucémicos por la modulación
inmunológica dada por el injerto. El primer determinante para la sobrevida de los pacientes …
inmunológica dada por el injerto. El primer determinante para la sobrevida de los pacientes …
[图书][B] Identification of the Deleted Gene (s) Associated with the Philadelphia Rearrangement Responsible for Poor Outcome in~ 20% of Patients with CML.
E Kolomietz - 2004 - library-archives.canada.ca
Using fluorescence in situ hybridization (FISH) we found that a significant percentage of
CML patients with a poor clinical response have submicroscopic deletions resulting in loss …
CML patients with a poor clinical response have submicroscopic deletions resulting in loss …
[图书][B] Molecular Monitoring of Chronic Myeloid Leukemia Treated with Imatinib Mesylate
Y Wei - 2007 - gupea.ub.gu.se
The BCR-ABL fusion gene product is a constitutively activated tyrosine kinase, which is
fundamental in the pathogenesis of chronic myeloid leukemia (CML). Imatinib mesylate …
fundamental in the pathogenesis of chronic myeloid leukemia (CML). Imatinib mesylate …